Details of the Drug Formulaction

General Information of Drug Formulation (ID: F13493)

• Formulation Name: Methotrexate 2.5 mg tablet
• Company: Mylan Pharamceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Methotrexate	(DM2TEOL)	Anterior urethra cancer		Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Allura red AC dye	(E00338)	33258	Colorant
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium carbonate monohydrate	(E00454)	2735133	Alkalizing agent; Buffering agent; Diluent; Dispersing agent
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant